Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)
Open Access
- 13 December 2006
- journal article
- case report
- Published by BMJ in British Journal of Ophthalmology
- Vol. 91 (5) , 602-604
- https://doi.org/10.1136/bjo.2006.108795
Abstract
Aim: To report the findings in a patient treated by repeated intravitreal bevacizumab (Avastin) injections, followed by macular relocation and excision of subfoveal choroidal neovascular membrane (CNV). Methods: Histopathological evaluation of the CNV specimen, including immunohistochemical assessment. Results: During surgical excision, the CNV seemed to be avascular and its underlying bed did not bleed. Histopathological examination revealed that the CNV comprised avascular fibrous subretinal tissue containing fibroblastic retinal pigment epithelial (RPE) cells, fragments of irregular thickened Bruch’s membrane and fibrotic choroidal tissue containing some medium-sized vessels but no choriocapillaris. Conclusions: The development of an RPE tear during the course of Avastin treatment may reflect contraction of the avascular subretinal tissue, whereas the lack of capillaries in both choroidal and subretinal components may be caused by the increased access of Avastin to the choriocapillaris in the presence of the RPE tear.Keywords
This publication has 10 references indexed in Scilit:
- The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBritish Journal of Ophthalmology, 2006
- Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degenerationBritish Journal of Ophthalmology, 2006
- Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular DegenerationAmerican Journal of Ophthalmology, 2006
- Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular NeovascularizationThe American Journal of Pathology, 2006
- Intravitreal Avastin: The Low Cost Alternative to Lucentis?American Journal of Ophthalmology, 2006
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Histopathologic and Ultrastructural Features of Surgically Excised Subfoveal Choroidal Neovascular LesionsArchives of Ophthalmology (1950), 2005
- Choroidal neovascularization: a wound healing perspective.2003
- Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findingsBritish Journal of Ophthalmology, 2003
- Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.1996